Since the outbreak of COVID-19 in 2020, acetaminophen has been performing well and will continue to do so throughout 2021. The main reason for this is because acetaminophen has become the default prescription for those with COVID-19, as ibuprofen is said to make symptoms worse. Therefore, across news outlets, social media, and word of mouth in Costa Rica, acetaminophen has become the go-to analgesic. Many consumers are also not sure whether they actually have COVID-19 and when symptoms emerge, a...

Euromonitor International’s Analgesics in Costa Rica report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.


Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.